# Prognostic Biomarkers for Selective Intra-Arterial Cooling Infusion Combined with Endovascular Thrombectomy in Acute Ischemic Stroke Based on Proteomics and Metabolomics.

> **NCT06665386** · — · RECRUITING · sponsor: **Capital Medical University** · enrollment: 258 (estimated)

## Conditions studied

- Stroke
- Hypothermia Treatment

## Interventions

- **PROCEDURE:** hypothermia

## Key facts

- **NCT ID:** NCT06665386
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-27
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 258 (ESTIMATED)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06665386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06665386, "Prognostic Biomarkers for Selective Intra-Arterial Cooling Infusion Combined with Endovascular Thrombectomy in Acute Ischemic Stroke Based on Proteomics and Metabolomics.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06665386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*